Ignite Creation Date:
2024-05-06 @ 3:14 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04564040
Status:
COMPLETED
Last Update Posted:
2020-12-29
First Post:
2020-08-27
Brief Title:
A Study in Healthy Subjects to Assess Bioavailability Proportion of a Drug Which Enters the Circulation to Have an Active Effect of Acalabrutinib Tablet and Protonpump Inhibitor Effect Members of a Class of Medications That Inhibits in Gastric Acid Production for Rabeprazole
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-11
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-27
First Submit QC Date:
September 23 2020
Study First Post Date:
2020-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-28
Last Update Post Date:
2020-12-29
Last Update Post Date Type:
ACTUAL